News Column

Investigators from King's College Have Reported New Data on Breast Cancer

February 3, 2014

By a News Reporter-Staff News Editor at Clinical Trials Week -- New research on Oncology is the subject of a report. According to news originating from London, United Kingdom, by NewsRx correspondents, research stated, "Magnetic nanoparticles (MNPs) possess unique properties, which make them highly attractive for medical applications."

Our news journalists obtained a quote from the research from King's College, "The use of MNPs in surgery has mainly been focused on their role in the identification of metastatic lymph node involvement. There have been developments within this field, including ongoing and newly conducted clinical trials."

According to the news editors, the research concluded: "The current published evidence for the use of MNPs in assessing metastatic lymph node spread using sentinel lymph node biopsy and non-invasive imaging modalities is reviewed and future applications considered."

For more information on this research see: What is the future of magnetic nanoparticles in the axillary management of breast cancer? Breast Cancer Research and Treatment, 2014;143(2):213-218. Breast Cancer Research and Treatment can be contacted at: Springer, 233 Spring St, New York, NY 10013, USA. (Springer -; Breast Cancer Research and Treatment -

The news correspondents report that additional information may be obtained from M. Ahmed, Kings Coll London, Dept. of Res Oncol, London SE1 9RT, United Kingdom (see also Oncology).

Keywords for this news article include: London, Europe, Oncology, Lymph Nodes, Nanoparticle, Breast Cancer, United Kingdom, Nanotechnology, Women's Health, Emerging Technologies, Hemic and Immune Systems, Clinical Trials and Studies

Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2014, NewsRx LLC

For more stories covering the world of technology, please see HispanicBusiness' Tech Channel

Source: Clinical Trials Week

Story Tools